Trials / Unknown
UnknownNCT02976142
The Efficacy of Surgical Treatment After Neoadjuvant Chemotherapy Plus Intraperitoneal Immunotherapy Versus Chemotherapy Alone for Patients With Positive Wash Cytology Gastric Cancer
Prospective Randomized Phase II Clinical Trial: the Efficacy of Surgical Treatment in Combinations With Intraperitoneal Immunotherapy and Systemic Chemotherapy in Patients With Gastric Cancer and Verified Free Cancer Cells
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Moscow Clinical Scientific Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether intraperitoneal immunotherapy (with interleykin-2 - human cytokine reaction activator) with systemic chemotherapy will be more effective than systemic chemotherapy alone in patients with gastric cancer and verified free cancer cells in abdominal cavity in improving the long term outcomes and overall survival of further surgical treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | neoadjuvant chemoimmunotherapy |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2018-11-01
- Completion
- 2020-12-01
- First posted
- 2016-11-29
- Last updated
- 2016-12-13
Source: ClinicalTrials.gov record NCT02976142. Inclusion in this directory is not an endorsement.